Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Nuwellis Inc (NUWE)

Nuwellis Inc (NUWE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Nuwellis, Inc. Regains Compliance with Nasdaq's Minimum Bid Price and Equity Requirements

Nuwellis, Inc. regains compliance with Nasdaq’s bid price and equity requirements, continuing to trade under symbol "NUWE".Quiver AI SummaryNuwellis, Inc. announced that it has regained compliance with...

NUWE : 1.0000 (-0.99%)
Nuwellis Regains Compliance with Nasdaq Listing Requirements

NUWE : 1.0000 (-0.99%)
Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights

NUWE : 1.0000 (-0.99%)
Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds

NUWE : 1.0000 (-0.99%)
Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid

NUWE : 1.0000 (-0.99%)
Nuwellis Announces Preliminary Results for Third Quarter of 2024

NUWE : 1.0000 (-0.99%)
Nuwellis Welcomes University of Iowa Health Care Stead Family Children’s Hospital as Newest Pediatric Customer

NUWE : 1.0000 (-0.99%)
Nuwellis, Inc. To Report Third Quarter 2024 Financial Results on November 11, 2024

NUWE : 1.0000 (-0.99%)
Global Rheumatoid Arthritis Drugs Market Expected To Hit US$ 70 Billion By 2030

EQNX::TICKER_START (NASDAQ:SILO),(NASDAQ:BXRX),(NASDAQ:HOTH),(NASDAQ:KALA),(NASDAQ:NUWE) EQNX::TICKER_END

SILO : 0.8780 (+5.16%)
BXRX : 0.0218 (+7.39%)
HOTH : 0.8100 (+5.21%)
KALA : 5.92 (-1.33%)
NUWE : 1.0000 (-0.99%)
Global Rheumatoid Arthritis Drugs Market Expected To Hit US$ 70 Billion By 2030

/PRNewswire/ -- According to the Centers for Disease Control and Prevention, arthritis affects approximately one in every four Americans, or 58.5 million...

SILO : 0.8780 (+5.16%)
BXRX : 0.0218 (+7.39%)
HOTH : 0.8100 (+5.21%)
KALA : 5.92 (-1.33%)
NUWE : 1.0000 (-0.99%)

Barchart Exclusives

Elon Musk Didn't Expect Tesla or SpaceX to be Succesful, But He Did It Because They "Were Important Enough to do Anyway"
In a reflection on his entrepreneurial journey, tech magnate Elon Musk offered a glimpse into the mindset that led him to launch two of the world’s most groundbreaking ventures: Tesla and SpaceX. Speaking on his early years of founding these companies, Musk said, “I always have optimism, but I’m realistic.... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar